Company News
Medicamen Biotech Reports No Fund Utilization Deviation
Medicamen Biotech files SEBI-mandated statement confirming no deviation in utilization of ₹53.57 crore funds raised via preferential issue.
The company utilized ₹29.30 crore of the raised amount for s
